Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 11,580 | 35,380 | 29,390 | 42,983 |
| Gross Profit | N/A | 11,580 | 35,380 | 29,390 | 42,983 |
| Operating Expenses | 689,524 | 498,765 | 293,659 | 217,398 | 153,680 |
| Operating Income | -689,524 | -487,185 | -258,279 | -188,008 | -110,697 |
| Interest Expense | 0 | 0 | 0 | 12 | 71 |
| Other Income | 88,678 | 47,294 | 9,154 | 929 | 2,238 |
| Pre-tax Income | -600,846 | -439,891 | -249,125 | -187,091 | -108,530 |
| Income Tax | -753 | -3,524 | -420 | N/A | -371 |
| Net Income Continuous | -600,093 | -436,367 | -248,705 | -187,091 | -108,159 |
| Net Income | $-600,093 | $-436,367 | $-248,705 | $-187,091 | $-108,159 |
| EPS Basic Total Ops | -3.58 | -3.86 | -3.08 | -2.57 | -2.01 |
| EPS Basic Continuous Ops | -3.58 | -3.86 | -3.08 | -2.57 | -1.97 |
| EPS Diluted Total Ops | -3.58 | -3.86 | -3.08 | -2.57 | -2.01 |
| EPS Diluted Continuous Ops | -3.58 | -3.86 | -3.08 | -2.57 | -1.97 |
| EPS Diluted Before Non-Recurring Items | -3.58 | -3.86 | -3.08 | -2.57 | -2.01 |
| EBITDA(a) | $-722,265 | $-500,081 | $-251,701 | $-177,664 | $-103,184 |